Merus BV (MRUS) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $90.00

About Merus BV

Merus NV is a clinical-stage biotechnology company based in Utrecht, Netherlands, focused on the development of bispecific antibody therapies designed to combat cancer. Leveraging its proprietary technology platform, the company creates targeted therapies that aim to enhance immune responses against tumors, fulfilling critical unmet needs in immuno-oncology. With a strong pipeline of innovative clinical candidates, Merus is well-positioned to contribute significantly to the advancing field of...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Merus BV and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does MRUS pay dividends?

Merus BV (MRUS) does not currently pay a regular dividend.